Tag: polycythemia vera treatment

Polycythemia vera treatment : Protagonist Therapeutics’ PTG-300 gets FDA ODD

pharmanewsdaily- June 18, 2020

Protagonist Therapeutics has bagged the orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for PTG-300 for polycythemia vera treatment. Polycythemia vera ... Read More